The Bloomberg BNA Intellectual Property Blog is the home of the "Do You Copy?" podcast and offers links to selected articles by the BNA IP team, which is accessible to both subscribers and non-subscribers as well as commentary and analysis exclusive to this blog.
Thursday, December 27, 2012
by Tony Dutra
Bloomberg BNA full story:
Tony Dutra's writeup of the Supreme Court's Dec. 7 cert grant on the question of whether a "pay-for-delay" settlement--in which a patent-owning brand name drug manufacturer pays a generic maker to cease its patent validity challenge in court--violates federal antitrust laws, appearing in BNA's Patent, Trademark & Copyright Law Daily (accessible to both subscribers and non-subscribers).
You must Sign In or Register to post a comment.
Ten Things You Need to Know About Social Media and Intellectual Property
If High Court Nixes Myriad Gene Patent, Look to Decades of Uncertainty, Panel Says
Following Remand, District Court Again Says YouTube Protected by DMCA's Safe Harbors
'Do You Copy?' Podcast, Episode 56, May 3, 2013
Former Franchisee's Continued Use of Marks After Agreement's Termination Was Infringing